Clinical trials · San Francisco, CA
Infections clinical trials in San Francisco
We’re tracking 71 recruiting infections studies with a site in or near San Francisco — including Phase 1, Phase 1/Phase 2, Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near San Francisco
- NCT07433985Recruiting
California mobile app study for men after jail release
This study tests a mobile app to help men recently released from jail or prison who use drugs or have sex with men stay healthy and avoid HIV. It's for people who don't have HIV and live in certain California counties.
Oakland, CaliforniaAges 18–59 - NCT07024641RecruitingPhase 1
Safety study of GIGA-2339 for chronic Hepatitis B
This study tests an experimental antibody (GIGA-2339) given as an infusion to people with chronic Hepatitis B. It aims to see if the drug is safe and how the body processes it, possibly helping to control the virus.
Oakland, CaliforniaAges 18 years+ - NCT07022678RecruitingPhase 3
Xylitol dental wipes to reduce infection risk in childhood leukemia
This trial tests whether using xylitol dental wipes can lower the risk of bloodstream infections in children with acute myeloid leukemia (AML) who are receiving chemotherapy. If you or your child have AML and will have at least two cycles of chemo that include cytarabine, this study may help reduce infection risk.
Oakland, CaliforniaAges 1–25 - NCT06824350Recruiting
Chlorine in water to prevent newborn infections
This trial tests whether adding a small amount of chlorine to the drinking water at public health facilities can reduce infections (including those resistant to antibiotics) in newborns. You and your baby may be eligible if you deliver at a participating facility that does not already chlorinate its water.
Berkeley, CaliforniaAges Any age - NCT07834853Recruiting
HIV prevention and care study for Latino men and transgender women
This study helps Latino men, transgender women, and nonbinary people in Washington, DC and the San Francisco Bay Area get HIV prevention or care services. It aims to connect you with health services and support, whether you are living with HIV or want to prevent it.
Berkeley, CaliforniaAges 18 years+ - NCT05603728Recruiting
Follow-up study for Exactech shoulder implants after surgery
This study follows people who get (or already had) a shoulder replacement to see how the implant is doing over time. It may help improve future care by tracking long-term performance and safety.
Redwood City, CaliforniaAges 21 years+ - NCT06909110RecruitingPhase 1/Phase 2
Immune cells for viral infections after transplant
This trial tests a treatment using specially trained immune cells (virus-specific T-cells) to fight stubborn infections with adenovirus, CMV, or EBV in people with weakened immune systems, such as after a stem cell or organ transplant.
Palo Alto, CaliforniaAges 1 month–65 years - NCT07387367RecruitingPhase 3
Comparing two drugs for adenovirus after stem cell transplant
This trial tests a new drug, brincidofovir (BCV), against an existing drug, cidofovir (CDV), for treating adenovirus infection in people who recently had a stem cell transplant. The goal is to see which works better with fewer side effects.
Palo Alto, CaliforniaAges 2 months+ - NCT04278404Recruiting
Drug safety study for children already on certain medicines
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
Palo Alto, CaliforniaAges birth–20 years - NCT05471908Recruiting
Compare automatic versus as-needed follow-up after common infections
This study compares two ways of scheduling a check-up after a child is hospitalized: an automatic visit or a visit only if needed (“as-needed”). It may help families and clinicians see which follow-up approach works best after illnesses like pneumonia, stomach flu (gastroenteritis), skin infections, or urinary tract infections.
Palo Alto, CaliforniaAges Up to 18 years - NCT06859424RecruitingPhase 2
Testing a new GVHD prevention method after donor stem cell transplant
This trial tests a new way to prevent graft-versus-host disease (a common side effect of stem cell transplant) using a drug called cyclophosphamide after transplant. It is for adults with certain blood cancers who need a transplant from a partially matched unrelated donor.
Palo Alto, CaliforniaAges 18–66 - NCT07095361RecruitingPhase 4
Daily enzyme therapy for infected pleural fluid
This trial tests a once-daily enzyme treatment given through a chest tube to clear infected fluid from around the lungs. It may help people with complicated pneumonia or empyema who still have fluid buildup after initial drainage.
Palo Alto, CaliforniaAges 18 years+ - NCT06257420Enrolling by invitation
Low-dose rapamycin for ME/CFS and Long-COVID
This trial tests whether a low dose of rapamycin, a drug that may help regulate the immune system, can improve symptoms in people with ME/CFS or Long-COVID.
Palo Alto, CaliforniaAges 18–65 - NCT06714864RecruitingPhase 4
Preventing catheter infections in children on dialysis
This study tests a liquid that is put into the dialysis catheter after each session to prevent infections that can happen through the catheter. It is designed for children up to age 18 who need hemodialysis through a catheter.
Palo Alto, CaliforniaAges Up to 17 years - NCT04579588Recruiting
Study flu vaccine immunity in people after COVID-19
This study looks at how well your immune system (your body’s infection-fighting system) responds to a flu vaccine after you’ve had COVID-19. It may help doctors understand why some people have different protection after vaccines.
Palo Alto, CaliforniaAges 9–64 - NCT02889016Recruiting
Markers study for children with PANS and healthy controls
This study looks at physical, immune, and brain-related “markers” in children with PANS and compares them with healthy children. It may help doctors understand what is happening in PANS and how to recognize it more clearly early on.
Palo Alto, CaliforniaAges 4–18 - NCT06866405RecruitingPhase 3
RSV vaccine boost in a new pregnancy
This study tests whether a second dose of the RSV vaccine during a new pregnancy protects you and your baby from RSV. If you received the RSVpreF or Abrysvo vaccine in a past pregnancy, you may be able to join.
Palo Alto, CaliforniaAges birth+ - NCT04191551Recruiting
Study of stomach precancer conditions during endoscopy
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
Stanford, CaliforniaAges 35–84 - NCT06877793Recruiting
Using dye imaging to diagnose severe flesh-eating infections
This trial tests a new way to quickly diagnose necrotizing soft tissue infections (NSTIs, also called flesh-eating infections) using a safe dye and a camera. If you are being checked for a possible NSTI, this could help doctors decide faster whether you have it and need treatment.
Stanford, CaliforniaAges 18 years+ - NCT05947071RecruitingPhase 2
Higher-dose flu vaccine versus standard dose in child transplant patients
This trial compares a higher-dose flu vaccine to the standard dose in children who recently received a kidney, heart, and/or liver transplant. It aims to see which dose better protects children against influenza while checking for safety.
Stanford, CaliforniaAges 3–17 - NCT03346694Recruiting
Testing a new chest dressing to prevent wound infections
This trial looks at whether a different dressing placed on the chest incision during certain heart surgeries can lower the risk of surgical wound infections. If you are having a sternotomy (a cut through the breastbone), this could help keep your incision cleaner while you heal.
Stanford, CaliforniaAges 18 years+ - NCT06785246Enrolling by invitation
Grasshopper dashboard study for chest x-rays
This trial tests a new dashboard tool for radiologists to review chest x-rays ordered during emergency or hospital stays. It aims to improve how scan results are reported and used.
Pleasanton, CaliforniaAges Any age - NCT07108660Recruiting
Predicting and reducing bloodstream infections from central lines
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
Napa, CaliforniaAges 18 years+
Hear when a new Infections trial opens near San Francisco, CA
We’ll email you when one opens near San Francisco, CA — at most once a week, no account needed, unsubscribe anytime.
Infections trials in other cities
Where these studies are running near San Francisco
Institutions with a site for the recruiting infections studies listed above.
- Stanford University · 8 studies
- Lucile Packard Children's Hospital Stanford · 4 studies
- Stanford Health Care · 2 studies
- CAL-PEP
- Center For Complex Diseases
- Grifols Investigative site
- Jessie Alexander
- Kaiser Permanente Northern California Division of Research
What taking part in a infections study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting infections studies in California.
Common questions
- Are there infections clinical trials near San Francisco?
- Yes. We're currently tracking 71 recruiting infections studies with a site near San Francisco, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a infections study near San Francisco?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in San Francisco to take part?
- Not necessarily. These studies have a site near San Francisco, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New infections studies open near San Francisco regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.